Klaus Kutz
Chief Tech/Sci/R&D Officer chez PROPANC BIOPHARMA, INC.
Profil
Klaus Kutz is associated with Propanc Biopharma, Inc., the University of Bonn, and RESprotect GmbH.
He holds the position of Chief Medical Officer at Propanc Biopharma, Inc. and RESprotect GmbH, and is a Professor at the University of Bonn.
Postes actifs de Klaus Kutz
Sociétés | Poste | Début |
---|---|---|
PROPANC BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | - |
RESprotect GmbH
RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Chief Tech/Sci/R&D Officer | 24/11/2009 |
University of Bonn | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
PROPANC BIOPHARMA, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
RESprotect GmbH
RESprotect GmbH Pharmaceuticals: OtherHealth Technology RESprotect GmbH develops drugs for the treatment of chemotherapeutic disease. It holds interest in the prevention and treatment of chemotherapeutic drug resistance and radiation therapyresistance. The firms offers products for the indication of cancer. The company was founded by Rudolf Fahrig in 2000 and is headquartered in Dresden, Germany. | Health Technology |